moxalactam has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB | 1 |
| Akiyoshi, T; Asakawa, S; Igimi, H; Konishi, M; Uchida, K | 1 |
2 other study(ies) available for moxalactam and Carcinoma
| Article | Year |
|---|---|
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Escherichia coli Infections; Female; Fever; Humans; Klebsiella Infections; Leukemia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Moxalactam; Neutropenia; Pseudomonas Infections; Sarcoma; Ticarcillin; Tobramycin | 1984 |
Biliary excretion of latamoxef and N-methyltetrazolethiol in humans and rats.
Topics: Animals; Azoles; Bile; Carcinoma; Cholelithiasis; Gallbladder Neoplasms; Humans; Injections, Intravenous; Male; Moxalactam; Pancreatic Neoplasms; Rats; Rats, Inbred Strains; Tetrazoles; Time Factors | 1985 |